Patent 9507477

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-pro

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

1 discretionary denial
Discretionary Denial
Filed
Sep 18, 2025
Last modified
Feb 18, 2026
Petitioner
BOE Technology Group Co., Ltd.
Inventor
Kouichi ANNO et al

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Based on the single AIA trial proceeding filed against US patent 9,507,477, here is an analysis of what happened and the implications for a defendant.

Proceedings overview

One IPR has been filed against this patent, and the PTAB declined to institute the trial on discretionary grounds, meaning the patent's validity was not decided on the merits. For a defendant, this means the patent has not been weakened or "hardened" by a PTAB trial, and all prior-art-based invalidity arguments remain available.

IPR2025-01483 — BOE Technology Group Co., Ltd. v. Paneltouch Technologies LLC

  • Type: Inter Partes Review
  • Filed: 2025-09-18
  • Status: Discretionary Denial — The Patent Trial and Appeal Board (PTAB) declined to institute a trial, so the merits of the petitioner's invalidity arguments were not considered. The proceeding terminated at this preliminary stage.
  • Judge panel: Because the proceeding was denied before institution, the judge panel that made the decision is not always made public in the same way as a full trial panel. However, the decision document itself would name the deciding judges.
  • Petition grounds: The petition reportedly challenged an unspecified set of claims based on prior art under 35 U.S.C. § 102 (anticipation) and/or § 103 (obviousness). The specific claims and prior art are detailed in the petition itself, which is available in the PTAB's online system.
  • Institution decision: The PTAB denied institution on 2026-02-18. A discretionary denial often occurs when there is a parallel district court litigation involving the same patent that is scheduled to go to trial before the PTAB's one-year deadline for a final decision. Under the Supreme Court's Thryv decision, such non-institution decisions are typically not appealable.
  • Final Written Decision: None issued, as the trial was not instituted.
  • Settlement / termination: The proceeding was terminated by the Board's denial of institution, not by a settlement between the parties.
  • Appeal: Not applicable. Decisions to deny institution are generally not appealable to the Federal Circuit.
  • Defensive value: This proceeding offers minimal defensive value. Because the PTAB did not rule on the merits, no claims were invalidated. Furthermore, because no trial was instituted, statutory estoppel under 35 U.S.C. § 315(e) does not attach to the petitioner (BOE Technology Group). A defendant today can raise the same arguments and prior art that BOE did, or any others it develops.

Strategic summary

The patent owner, Paneltouch Technologies LLC, successfully avoided a substantive PTAB review of US patent 9,507,477. The single IPR filed against the patent was terminated via a discretionary denial, a procedural outcome that does not address the validity of the patent claims.

  • Claim Status: All claims of US patent 9,507,477 remain UNTESTED by the PTAB. No claims have been canceled or sustained in an AIA proceeding.
  • Estoppel Landscape: Critically for any current or future defendant, no IPR estoppel has been created. Estoppel under 35 U.S.C. § 315(e)(2), which prevents a petitioner from later asserting invalidity grounds in district court that it "raised or reasonably could have raised" in the IPR, only attaches if the PTAB issues a Final Written Decision. Since the IPR was denied at the institution stage, the petitioner (BOE) is not estopped, and neither is any other party. All prior art grounds remain available for a new defendant to use in either a new IPR petition or in district court.
  • Pattern Signals: The patent was assigned to Paneltouch Technologies LLC in April 2024, a common pattern for patents acquired for assertion campaigns. The filing of an IPR by a major operating company like BOE Technology Group in September 2025, followed by a discretionary denial, strongly suggests there is co-pending district court litigation. Patent owners often leverage the speed and schedule of certain district courts (like the Eastern and Western Districts of Texas) to argue for discretionary denials at the PTAB under the Fintiv framework.

Recommended next steps

For a defendant facing a demand letter citing US patent 9,507,477:

  • Confirm Parallel Litigation: The first step is to confirm the existence and status of any district court litigation. The discretionary denial in IPR2025-01483 makes this highly likely. The case is likely Paneltouch Technologies LLC v. BOE Technology Group Co., Ltd.. Investigate the docket to see the infringement contentions, claim construction orders, and invalidity arguments being made there.
  • Evaluate IPR Petition: Obtain and analyze the IPR petition filed by BOE Technology Group. While the PTAB did not rule on its merits, it represents a professionally prepared set of invalidity arguments that can be a valuable starting point for your own invalidity analysis. Since no estoppel applies, these grounds can be reused.
  • No Claims Canceled: Be aware that the patent owner can truthfully state that the patent "survived" a PTAB challenge. However, it is crucial to understand that it survived procedurally, not on the substantive merits of its validity. No claims have been confirmed or canceled, and the patent is no stronger or weaker today than it was before the IPR was filed.

Generated 5/13/2026, 12:48:33 PM